Article · 29 Nov 2024
Byline
N. Ranganathan
Articles whose byline reads N. Ranganathan, printed as Natarajan Ranganathan, Nataraja Ranganathan and Nathan Ranganathan. Different authors can share a byline.
- Articles
- 15
- Latest year
- 2024
Articles
Newest first. Showing 1–15 of 15 articles.
Mini review · 31 Jan 2024
Targeting Inflammation to Slow CKD Progression- Role of Gut Microbiome Based Therapy
Editorial · 3 May 2023
Environmental Heat Stress or Toxins: Why Are We Waiting to Explore Treatment Options for CKDu?
Mini review · 26 Sep 2022
Differentiating Sodium-Glucose Cotransporter 2 Inhibitors from Live Biotherapeutic Products (Probiotics) as Novel Therapeutic Intervention to Slow CKD Progression
Perspective · 28 Jan 2022
A Brief Note on Drug Allergies
Research article · 27 Jul 2021
A Double-Blind Randomized, Placebo-Controlled Phase 2 Clinical Trial to Evaluate Safety and Efficacy of US APR 2020 in Subjects with Chronic Kidney Disease Stage IV
Article · 2018
Reality of
Commentary · 2018
Reality of "Enteric Dialysis ®" with Probiotics and Prebiotics to Delay the Need of Conventional Dialysis
Conference abstract · 13 Jul 2015
The concept and potential of enteric dialysis, the gut – Kidney connection
Conference abstract · 13 Jul 2015
The concept and potential of enteric dialysis, the gut – Kidney connection
Conference abstract · 13 Jul 2015
Therapeutical applications and pharmaceutical development of natural products
Article · 2015
Concept and Potential of Enteric Dialysisand#174; - Treating the Cause of Dysbiosis and not the Symptoms in Chronic Kidney Diseases (CKD)
Commentary · 2015
Concept and Potential of Enteric Dialysis® - Treating the Cause of Dysbiosis and not the Symptoms in Chronic Kidney Diseases (CKD)
Article · 2013
Dose Escalation, Safety and Impact of a Strain-Specific Probiotic (Renadyland#8482;) on Stages III and IV Chronic Kidney Disease Patients
Research article · 2013

